Número de publicaciones
572
Buscador de publicaciones
  • Eritja, N; Jove, M; Fasmer, KE; Gatius, S; Portero-Otin, M; Trovik, J; Krakstad, C; Sol, J; Pamplona, R; Haldorsen, IS; Matias-Guiu, X

    Tumour-microenvironmental blood flow determines a metabolomic signature identifying lysophospholipids and resolvin D as biomarkers in endometrial cancer patients

    Oncotarget 8 109018-109026. .

    [doi:10.18632/oncotarget.22558]

  • Depreeuw, J; Stelloo, E; Osse, EM; Creutzberg, CL; Nout, RA; Moisse, M; Garcia-Dios, DA; Dewaele, M; Willekens, K; Marine, JC; Matias-Guiu, X; Amant, F; Lambrechts, D; Bosse, T

    Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma

    CLINICAL CANCER RESEARCH 23 7232-7241. .

    [doi:10.1158/1078-0432.CCR-17-0566]

  • Martinez-Garcia, E; Lesur, A; Devis, L; Cabrera, S; Matias-Guiu, X; Hirschfeld, M; Asberger, J; van Oostrum, J; Casares de Cal MLÁ; Gomez-Tato, A; Reventos, J; Domon, B; Colas, E; Gil-Moreno, A

    Targeted Proteomics Identifies Proteomic Signatures in Liquid Biopsies of the Endometrium to Diagnose Endometrial Cancer and Assist in the Prediction of the Optimal Surgical Treatment

    CLINICAL CANCER RESEARCH 23 6458-6467. .

    [doi:10.1158/1078-0432.CCR-17-0474]

  • Garrido, P; Aldaz, A; Calleja, MA; de Alava, E; Lamas, MJ; Martin, M; Matias-Guiu, X; Palacios, J; Vera, R

    Proposal for the Creation of a National Strategy for Precision Medicine in Cancer: a position statement of SEOM, SEAP and SEFH

    FARMACIA HOSPITALARIA 41 688-691. .

    [doi:10.7399/fh.10877]

  • Novell, A; Morales, S; Valls J; Panades, MJ; Salud, A; Iglesias, E; Vilardell, F; Matias-Guiu, X; Llombart-Cussac, A

    Novel biomarkers in primary breast core biopsies to predict poor response to neoadjuvant chemotherapy and appearance of metastases

    HISTOLOGY AND HISTOPATHOLOGY 32 909-915. .

    [doi:10.14670/HH-11-849]

  • García-de-la-Fuente MR; Santacana, M; Vilardell, F; Pujol, RM; Gari, E; Casanova, JM

    Vulvar Basal Cell Carcinoma: Four Case Reports With Immunohistochemical Study

    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY 21 457-459. .

    [doi:10.1177/1203475417712498]

  • Le Gallo, M; Rudd, ML; Urick, ME; Hansen, NF; Zhang, S; NISC Comparative Sequencing Program; Lozy F; Sgroi DC; Vidal Bel A; Matias-Guiu X; Broaddus RR; Lu KH; Levine DA; Mutch DG; Goodfellow PJ; Salvesen HB; Mullikin JC; Bell DW

    Somatic Mutation Profiles of Clear Cell Endometrial Tumors Revealed by Whole Exome and Targeted Gene Sequencing

    CANCER 123 3261-3268. .

    [doi:10.1002/cncr.30745]

  • Morales, S.; Gasol Cudos, A.; Novell Alvarez, A.; Vilardell Villellas, F.; Panades Siurana, M. J.; Canosa Morales, C.; Mele Olive, J.; Iglesias Martinez, E.

    Vitamin D as a prognostic factor in triple negative early breast cancer

    ANNALS OF ONCOLOGY 28 -. .

  • Altadill, T; Dowdy, TM; Gill, K; Reques, A; Menon, SS; Moiola, CP; Lopez-Gil, C; Coll, E; Matias-Guiu, X; Cabrera, S; Garcia, A; Reventos, J; Byers, SW; Gil-Moreno, A; Cheema, AK; Colas, E

    Metabolomic and Lipidomic Profiling Identifies The Role of the RNA Editing Pathway in Endometrial Carcinogenesis

    SCIENTIFIC REPORTS 7 8803-8803. .

    [doi:10.1038/s41598-017-09169-2]

  • Eritja, N; Felip, I; Dosil, MA; Vigezzi, L; Mirantes, C; Yeramian, A; Navaridas, R; Santacana, M; Llobet-Navas, D; Yoshimura, A; Nomura, M; Encinas, M; Matias-Guiu, X; Dolcet, X

    A Smad3-PTEN regulatory loop controls proliferation and apoptotic responses to TGF-beta in mouse endometrium

    CELL DEATH AND DIFFERENTIATION 24 1443-1458. .

    [doi:10.1038/cdd.2017.73]

  • Alsina-Sanchis, E; Figueras, A; Lahiguera, A; Gil-Martin, M; Pardo, B; Piulats, JM; Marti, L; Ponce, J; Matias-Guiu, X; Vidal, A; Villanueva, A; Viñals F

    TGF Controls Ovarian Cancer Cell Proliferation

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 18 -. .

    [doi:10.3390/ijms18081658]

  • Alfon, J.; Erazo, T.; Perez-Montoyo, H.; Domenech, C.; Puig, T.; Segura, M. F.; Matias-Guiu, X.; Rodon, J.; Nadal, E.; Oaknin, A.; Gil, M.; Vidal, L.; Gascon, P.; Lizcano, J. M.

    ABTL0812 AN AUTOPHAGY-ANTICANCER DRUG IN PHASE II CLINICAL TRIALS THAT INHIBITS PI3K/AKT/MTOR PATHWAY BY INDUCING TRIB3 EXPRESSION

    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 121 30-30. .